血液・腫瘍内科について

HOME > 血液・腫瘍内科について > 業績

業績

2009

原著

Kanaji S, Kanaji T, Honda M, Nakasato S, Wakayama K, Tabata Y, Shibata A, Gondo H, Nakamura I, Node K, Miura M, Miyahara M, Okamura T, Nagumo F, Ohta S, Izuhara K.
Identification of four novel mutations in F5 associated with congenital factor V deficiency.
Int J Hematol 89: 71-75, 2009
Ohtsubo K, Sata M, Kawaguchi T, Morishige S, Takata Y, Oku E, Imamura R, Seki R, Hashiguchi M, Osaki K, Yakushiji K, Kanaji T, Yoshimoto K, Ueno T, Okamura T.
Characterization of the light chain-restricted clonal B cells in peripheral blood of HCV-positive patients.
Int J Hematol 89: 452-459, 2009
Seki R, Ohshima K, Fujisaki T, Uike N, Kawano F, Gondo H, Makino S, Eto T, Moriuchi Y, Taguchi F, Kamimura T, Tsuda H, Ogawa R, Shimoda K, Yamashita K, Suzuki K, Suzushima H, Tsukazaki K, Higuchi M, Utsunomiya A, Iwahashi M, Imamura Y, Tamura K, Suzumiya J, Yoshida M, Abe Y, Matsumoto T, Okamura T.
Prognostic impact of immunohistochemical biomarkers in diffuse large B-cell lymphoma in the rituximab era.
Cancer Sci100: 1842-1847, 2009
Abe Y, Ito T, Baba E, Nagafuji K, Kawabe K, Choi I, Arita Y, Miyamoto T, Teshima T, Nakano S, Harada M.
Nonmyeloablative allogeneic hematopoietic stem cell transplantation as immunotherapy for pancreatic cancer.
Pancreas. 2009;38:815-819.
Yamauchi T,Mori Y,Miyamoto T,Kamezaki K,Aoki T,Yamamoto A,Takenaka K,Iwasaki H,Harada N,Nagafuji K,Teshima T,Akashi K.
Second unrelated cord blood transplantation using a reduced-intensity conditioning regimen combined with gemtuzumab ozogamicin in patients with relapsed acute myelogenous leukemia.
Int J Hematol 416-420 2009
Kohno K, Nagafuji K, Tsukamoto H, Horiuchi T, Takase K, Aoki K, Henzan H, Kamezaki K, Takenaka K, Miyamoto T, Teshima T, Harada M, Akashi K.
Infectious complications in patients receiving autologous CD34-selected hematopoietic stem cell transplantation for severe autoimmune diseases.
Transpl Infect Dis. 2009;11:318-323.
Yoshimoto G, Miyamoto T, Jabbarzadeh-Tabrizi S, Iino T, Rocnik JL, Kikushige Y, Mori Y, Shima T, Iwasaki H, Takenaka K, Nagafuji K, Mizuno S, Niiro H, Gilliland GD, Akashi K.
FLT3-ITD up-regulates MCL-1 to promote survival of stem cells in acute myeloid leukemia via FLT3-ITD-specific STAT5 activation.
Blood. 2009;114:5034-5043.
Hidaka T, Shide K, Shimoda H, Kameda T, Toyama K, Katayose K, Kubuki Y, Nagata K, Takenaka K, Akashi K, Okamura T, Niho Y, Mizoguchi H, Omine M, Ozawa K, Harada M, Shimoda K.
The impact of cytogenetic abnormalities on the prognosis of primary myelofibrosis: a prospective survey of 202 cases in Japan.
Eur J Haematol 83: 328-333, 2009

症例報告

小池清美 深水圭 森重聡 玻座真琢磨 田口顕正 安藤亮太郎 永野真喜雄 吉村潤子 上田誠二 橋口道俊 玉置清志 西田秀美 奥田誠也
Zoledronic acid(ゾメタ)投与を契機に急性腎不全を発症し維持透析導入を要した多発性骨髄腫患者の1例
日本腎臓学会誌 51(5):557-62 2009
Kaibara H, Kaida H, Ishibashi M, Kurata S, Otsubo K, Fujimoto K, Uchida M, Abe T, Kobayashi M, Doi R, Kunou Y, Okamura T, Oshima K, Hayabuchi N.
18F-FDG-PET findings of rare case of nonsecretory plasmablastic myeloma.
Ann nucl Med 23: 807-811, 2009

血液・腫瘍内科について
教授あいさつ
スタッフ
沿革
研究紹介
業績
  • 患者さんへ
  • 医療関係者の方へ
久留米大学医学部 内科学講座
血液・腫瘍内科部門
〒830-0011
福岡県久留米市旭町67
TEL:0942-31-7852
FAX:0942-31-7854
  • 久留米大学 セカンドオピニオン外来
  • 久留米大学
  • 久留米大学病院